title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday",20220705T083503,https://www.benzinga.com/news/22/07/27948361/accolade-shares-jump-around-29-heres-75-biggest-movers-from-friday,BLCM,0.061758,Neutral,0.002558
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,BLCM,0.021778,Neutral,-0.020221
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,BLCM,0.02074,Neutral,-0.062117
"Why LL Flooring Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - AcelRx Pharmaceuticals  ( NASDAQ:ACRX ) , Aclarion  ( NASDAQ:ACON ) ",20230531T123927,https://www.benzinga.com/news/23/05/32645917/why-ll-flooring-shares-are-trading-higher-by-19-here-are-20-stocks-moving-premarket,BLCM,0.151539,Somewhat-Bullish,0.250693
Bellicum Pharmaceuticals  ( NASDAQ:BLCM )  Coverage Initiated by Analysts at StockNews.com,20230609T055845,https://www.defenseworld.net/2023/06/09/bellicum-pharmaceuticals-nasdaqblcm-coverage-initiated-by-analysts-at-stocknews-com-2.html,BLCM,0.940989,Somewhat-Bullish,0.294811
"CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",20230925T210100,https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html,BLCM,0.018757,Neutral,0.012868
Global Engineered T Cells Market Report 2022-2027: Increasing Demand for Innovative Biopharmaceutical Therapies & Recent Advances in CAR-T Cell Engineering Propelling Sector,20220811T124836,https://www.benzinga.com/pressreleases/22/08/g28454185/global-engineered-t-cells-market-report-2022-2027-increasing-demand-for-innovative-biopharmaceutic,BLCM,0.039745,Neutral,0.0
"Why Blue Bird Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket - Addex Therapeutics  ( NASDAQ:ADXN ) , Babylon Holdings  ( NYSE:BBLN ) ",20230512T122010,https://www.benzinga.com/news/23/05/32362712/why-blue-bird-shares-are-trading-higher-by-30-here-are-20-stocks-moving-premarket,BLCM,0.155954,Somewhat-Bullish,0.221257
"Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Alcoa  ( NYSE:AA ) , Ambipar Emergency  ( AMEX:AMBI ) ",20230315T172047,https://www.benzinga.com/news/23/03/31366460/why-american-public-education-shares-are-trading-lower-by-around-49-here-are-other-stocks-moving-in,BLCM,0.092569,Neutral,-0.119808
83 Biggest Movers From Yesterday,20220609T094429,https://www.benzinga.com/news/22/06/27622472/83-biggest-movers-from-yesterday,BLCM,0.050572,Neutral,0.004559
"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen",20230913T210100,https://www.prnewswire.com/news-releases/acute-lymphocytic-leukemia-market-to-accelerate-substantially-by-2032-assesses-delveinsight--key-companies-in-the-market---beam-pfizer-genentech-abbvie-fate-roche-ascentage-janssen-jazz-adc-kymera-syndax-immunogen-301925772.html,BLCM,0.021897,Neutral,0.047845
